Updated overview of current biomarkers in head and neck carcinoma.

Squamous cell cancer is the most common type of malignancy arising from the epithelial cells of the head and neck region. Head and neck squamous cell carcinoma (HNSCC) is one of the predominant causes of cancer related casualties worldwide. Overall prognosis in this disease has improved to some extent with the advancements in therapeutic modalities but detection of primary tumor at its initial stage and prevention of relapse are the major targets to be achieved for further improvement in terms of survival rate of patients. Latest achievements in basic research regarding molecular characterization of the disease has helped in better perception of the molecular mechanisms involved in HNSCC progression and also in recognizing and targeting various molecular biomarkers associated with HNSCC. In the present article, we review the information regarding latest and potential biomarkers for the early detection of HNSCC. A detailed molecular characterization, ultimately, is likely to improve the development of new therapeutic strategies, potentially relevant to diagnosis and prognosis of head and neck cancers. The need for more accurate and timely disease prediction has generated enormous research interests in this field.

[1]  J. Herman,et al.  Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. , 2000, Cancer research.

[2]  David Elashoff,et al.  Salivary Transcriptome Diagnostics for Oral Cancer Detection , 2004, Clinical Cancer Research.

[3]  K. Lee,et al.  Body fluid biomarkers for early detection of head and neck squamous cell carcinomas. , 2011, Anticancer research.

[4]  B. Fingleton,et al.  Matrix metalloproteinases: biologic activity and clinical implications. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  P. Chu,et al.  Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases , 2000, Modern Pathology.

[6]  Xiao-Cheng Wu,et al.  Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control , 2008, Journal of the National Cancer Institute.

[7]  H. Song,et al.  Prognostic significance of immunohistochemical expression of p53 gene product in operable breast cancer. , 2006, Cancer research and treatment : official journal of Korean Cancer Association.

[8]  Jong-Wook Park,et al.  Lung cancer detection by a RT-nested PCR using MAGE A1--6 common primers. , 2004, Lung cancer.

[9]  C. Smith,et al.  Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  E. Nkenke,et al.  Cytokeratin 17 mRNA expression has potential for diagnostic marker of oral squamous cell carcinoma , 2008, Journal of Cancer Research and Clinical Oncology.

[11]  Shu-Chun Lin,et al.  Frequent microsatellite alterations of chromosome locus 4q13.1 in oral squamous cell carcinomas. , 2005, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[12]  J. Califano,et al.  Advances and Perspectives in the Molecular Diagnosis of Head and Neck Cancer. , 2010, Expert opinion on medical diagnostics.

[13]  F. Tsai,et al.  Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[14]  John V. Carlis,et al.  Quantitative Proteomics Reveals Myosin and Actin as Promising Saliva Biomarkers for Distinguishing Pre-Malignant and Malignant Oral Lesions , 2010, PloS one.

[15]  P. Friedl,et al.  Collective cell migration in morphogenesis, regeneration and cancer , 2009, Nature Reviews Molecular Cell Biology.

[16]  Qing‐Yu He,et al.  Comparative proteomic analysis of esophageal squamous cell carcinoma , 2005, Proteomics.

[17]  J. Werner,et al.  Cytokeratins 6 and 16 are frequently expressed in head and neck squamous cell carcinoma cell lines and fresh biopsies. , 2005, Anticancer research.

[18]  F. Abreo,et al.  Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications. , 2000, Cancer research.

[19]  H. Chang,et al.  Expression of MAGE A 1-6 mRNA in sputa of head and neck cancer patients--a preliminary report. , 2006, Anticancer research.

[20]  Dong Eun Kim,et al.  Detection of MAGE and SSX Gene Expressions by RT-nested PCR Using Common Primers in Head and Neck Cancer , 2008, Clinical and experimental otorhinolaryngology.

[21]  P. Bradley,et al.  New molecular diagnostic methods in head and neck cancer , 2005, Head & neck.

[22]  F. Gilliland,et al.  Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. , 2002, Cancer research.

[23]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[24]  Long-Bang Chen,et al.  Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma. , 2009, Lung cancer.

[25]  J. Manola,et al.  TP53 mutations and survival in squamous-cell carcinoma of the head and neck. , 2007, The New England journal of medicine.

[26]  A. Simpson,et al.  Detection of oral and oropharyngeal cancer by microsatellite analysis in mouth washes and lesion brushings. , 2000, Oral oncology.

[27]  V. Grégoire,et al.  PET imaging biomarkers in head and neck cancer , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[28]  K. Krapfenbauer,et al.  Identification of differentially expressed, tumor‐associated proteins in oral squamous cell carcinoma by proteomic analysis , 2006, Electrophoresis.

[29]  P. Parsons,et al.  Molecular introduction to head and neck cancer (HNSCC) carcinogenesis. , 2004, British journal of plastic surgery.

[30]  A. Nadal,et al.  Carcinoma of the head and neck in the HPV era. , 2011, Acta dermatovenerologica Alpina, Pannonica, et Adriatica.

[31]  S. Chakraborty,et al.  Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma , 2008, BMC Cancer.

[32]  E. Prakash,et al.  CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway. , 2008, Carcinogenesis.

[33]  S. Prime,et al.  Spindle assembly checkpoint and centrosome abnormalities in oral cancer. , 2007, Cancer letters.

[34]  P. Roche,et al.  Identification of NY‐ESO‐1, MAGE‐1, and MAGE‐3 in head and neck squamous cell carcinoma , 2003, Head & neck.

[35]  R. Kannagi,et al.  Expression of CC-chemokine receptor 7 (CCR7) and CXC-chemokine receptor 4 (CXCR4) in head and neck squamous cell carcinoma. , 2010, Auris, nasus, larynx.

[36]  E. Sabo,et al.  Cytokeratin-17 as a Potential Marker for Squamous Cell Carcinoma of the Larynx , 2004, The Annals of otology, rhinology, and laryngology.

[37]  S. Somiari,et al.  Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer. , 2006, Cancer letters.

[38]  A. Kaufmann,et al.  MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro. , 2015, International journal of oncology.

[39]  E. Sabo,et al.  Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  David Hardisson,et al.  Molecular pathogenesis of head and neck squamous cell carcinoma , 2003, European Archives of Oto-Rhino-Laryngology.

[41]  Shan-zhen Sun,et al.  Expression of stromal CD34 and α-smooth muscle actin in oral invasive cancer , 2006 .

[42]  Benjamin D. L. Li,et al.  Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer , 1997, Oncogene.

[43]  Jens Overgaard,et al.  Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  D. Speiser,et al.  Pattern and clinical significance of cancer‐testis gene expression in head and neck squamous cell carcinoma , 2011, International journal of cancer.

[45]  K. Fukasawa,et al.  Loss of p53 and centrosome hyperamplification , 2002, Oncogene.

[46]  J. Graff,et al.  eIF-4E expression and its role in malignancies and metastases , 2004, Oncogene.

[47]  Tim Crook,et al.  The p53 network in head and neck cancer. , 2003, Oral oncology.

[48]  A. Juretić,et al.  Prognostic value of MAGE‐A and NY‐ESO‐1 expression in pharyngeal cancer , 2010, Head & neck.

[49]  M. Alonso-Guervós,et al.  Analysis of Microsatellite Instability in Laryngeal Squamous Cell Carcinoma , 2012 .

[50]  C. Romanini,et al.  Increased serum 72 KDa metalloproteinase in serous ovarian tumors: comparison with CA 125. , 1996, Anticancer research.

[51]  A. Harris,et al.  Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression , 1999, British Journal of Cancer.

[52]  C. R. Leemans,et al.  Protein biomarker discovery for head and neck cancer. , 2010, Journal of proteomics.

[53]  J. Wiltfang,et al.  Investigation of the expression of melanoma antigen-encoding genes (MAGE-A1 to -A6) in oral squamous cell carcinomas to determine potential targets for gene-based cancer immunotherapy. , 2005, International journal of oncology.

[54]  N. Park,et al.  Salivary microRNA: Discovery, Characterization, and Clinical Utility for Oral Cancer Detection , 2009, Clinical Cancer Research.

[55]  G. Cheon,et al.  Usefulness of Integrated PET/MRI in Head and Neck Cancer: A Preliminary Study , 2013, Nuclear Medicine and Molecular Imaging.

[56]  L. Villa,et al.  Impact of HPV infection on the development of head and neck cancer , 2013, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[57]  M. Correnti,et al.  Human papillomavirus detection in head and neck squamous cell carcinoma , 2014, Ecancermedicalscience.

[58]  A. Simpson,et al.  MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines. , 2007, Cancer research.

[59]  A. Heidarzadeh,et al.  p53 overexpression impacts on the prognosis of laryngeal squamous cell carcinomas. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[60]  De-Pei Liu,et al.  MicroRNAs: key participants in gene regulatory networks. , 2003, Current opinion in chemical biology.

[61]  G. Ling,et al.  Smoking and drinking can induce p15 methylation in the upper aerodigestive tract of healthy individuals and patients with head and neck squamous cell carcinoma , 2004, Cancer.

[62]  G. Snow,et al.  Mutated p53 as a molecular marker for the diagnosis of head and neck cancer , 2002, The Journal of pathology.

[63]  M. Louka,et al.  Evaluation of matrix metalloproteinase‐2 in lung cancer , 2014, Proteomics. Clinical applications.

[64]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[65]  W. A. Yeudall,et al.  Down-regulation of CXCL5 inhibits squamous carcinogenesis. , 2006, Cancer research.

[66]  K. Odunsi,et al.  Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy. , 2010, Future oncology.

[67]  Y. Zeng,et al.  Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome , 2005, Journal of Translational Medicine.

[68]  T. Godfrey,et al.  Expression Pattern of Chemokine Receptor 6 (CCR6) and CCR7 in Squamous Cell Carcinoma of the Head and Neck Identifies a Novel Metastatic Phenotype , 2004, Cancer Research.

[69]  C. Meschonat,et al.  A Prospective Trial on Initiation Factor 4E (eIF4E) Overexpression and Cancer Recurrence in Node-Negative Breast Cancer , 2008, Annals of Surgical Oncology.

[70]  E. Ioachim,et al.  Biomarkers of head and neck cancer, tools or a gordian knot? , 2015, International journal of clinical and experimental medicine.

[71]  Yuriy Gusev,et al.  Real-time expression profiling of microRNA precursors in human cancer cell lines , 2005, Nucleic acids research.

[72]  J. M. Thomson,et al.  MicroRNA expression profiles in head and neck cancer cell lines. , 2007, Biochemical and biophysical research communications.

[73]  King-Jen Chang,et al.  Expression of eukaryotic initiation factor 4E in gastric adenocarcinoma and its association with clinical outcome , 2004, Journal of surgical oncology.

[74]  W. Pepiński,et al.  Evaluation of tumor microsatellite instability in laryngeal cancer using five quasimonomorphic mononucleotide repeats and pentaplex PCR. , 2008, Advances in medical sciences.

[75]  K. Fukasawa,et al.  Centrosome Hyperamplification in Head and Neck Squamous Cell Carcinoma: A Potential Phenotypic Marker of Tumor Aggressiveness , 2000, The Laryngoscope.

[76]  O. Kent,et al.  A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes , 2006, Oncogene.

[77]  H. Quon,et al.  FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma. , 2012, Imaging in medicine.

[78]  Faina Linkov,et al.  Early Detection of Head and Neck Cancer: Development of a Novel Screening Tool Using Multiplexed Immunobead-Based Biomarker Profiling , 2007, Cancer Epidemiology Biomarkers & Prevention.

[79]  Victor G Prieto,et al.  Metastatic basal cell carcinoma exhibits reduced actin expression , 2008, Modern Pathology.

[80]  N. Dalay,et al.  Assessment of microsatellite instability in head and neck cancer using consensus markers , 2010, Molecular Biology Reports.

[81]  U. Moll,et al.  Mr 92,000 Type IV Collagenase Is Increased in Plasma of Patients with Colon Cancer and Breast Cancer , 1993 .

[82]  J. Werner,et al.  Tumor marker potential of serum matrix metalloproteinases in patients with head and neck cancer. , 2002, Anticancer research.

[83]  William Lee,et al.  Unraveling the molecular genetics of head and neck cancer through genome-wide approaches , 2014, Genes & diseases.

[84]  A. Zaravinos An updated overview of HPV-associated head and neck carcinomas , 2014, Oncotarget.

[85]  Y. Maehara,et al.  The instability within: problems in current analyses of microsatellite instability. , 2001, Mutation research.

[86]  D. Sidransky,et al.  Head and neck cancer. , 2001, The New England journal of medicine.

[87]  D. Speiser,et al.  MAGE-A3 and MAGE-A4 specific CD4+ T cells in head and neck cancer patients: detection of naturally acquired responses and identification of new epitopes , 2010, Cancer Immunology, Immunotherapy.

[88]  E. Nkenke,et al.  MAGE-A as a novel approach in the diagnostic accuracy of oral squamous cell cancer: a case report , 2009, Head & neck oncology.

[89]  L. Mariani,et al.  High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[90]  Keith D Robertson,et al.  DNA methyltransferases, DNA damage repair, and cancer. , 2013, Advances in experimental medicine and biology.

[91]  Hsueh-Wei Chang,et al.  Matrix metalloproteinases (MMP) 1 and MMP10 but not MMP12 are potential oral cancer markers , 2009, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[92]  Andrew Feber,et al.  MicroRNA expression profiles of esophageal cancer. , 2008, The Journal of thoracic and cardiovascular surgery.

[93]  Wei Shi,et al.  Comprehensive MicroRNA Profiling for Head and Neck Squamous Cell Carcinomas , 2010, Clinical Cancer Research.

[94]  Cun-Yu Wang,et al.  CXCL12/SDF-1α Activates NF-κB and Promotes Oral Cancer Invasion through the Carma3/Bcl10/Malt1 Complex , 2009, International Journal of Oral Science.

[95]  B. Cakmakoglu,et al.  MCP-1 and CCR2 gene variants in oral squamous cell carcinoma. , 2012, Oral diseases.

[96]  Christoph Lahtz,et al.  Epigenetic changes of DNA repair genes in cancer. , 2011, Journal of molecular cell biology.

[97]  H. Goike,et al.  Clinical utility of cytokeratins as tumor markers. , 2004, Clinical biochemistry.

[98]  E. Srivatsan,et al.  Suppression of interleukin 6 and 8 production in head and neck cancer cells with curcumin via inhibition of Ikappa beta kinase. , 2009, Archives of otolaryngology--head & neck surgery.

[99]  Ratnesh K Singh,et al.  Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population , 2006, Journal of Clinical Pathology.

[100]  E. Vairaktaris,et al.  Expression of cytokeratin 17 mRNA in oral squamous cell carcinoma cells obtained by brush biopsy: preliminary results. , 2009, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[101]  N. Park,et al.  Genomic Targets in Saliva , 2007, Annals of the New York Academy of Sciences.

[102]  J. Wiltfang,et al.  Expression of melanoma-associated antigens in oral squamous cell carcinoma. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[103]  C. Chung,et al.  Emerging biomarkers in head and neck cancer in the era of genomics , 2015, Nature Reviews Clinical Oncology.

[104]  P. Slootweg,et al.  Gain-of-function mutations in the tumor suppressor gene p53. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[105]  P. Pandolfi,et al.  The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis , 2004, Nature Medicine.

[106]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[107]  N. Sonenberg,et al.  eIF4E – from translation to transformation , 2004, Oncogene.

[108]  A. Eisbruch,et al.  Biomarkers in advanced larynx cancer , 2014, The Laryngoscope.

[109]  B. Perez-Ordonez,et al.  Molecular biology of squamous cell carcinoma of the head and neck , 2006, Journal of Clinical Pathology.

[110]  J. R. de los Toyos,et al.  The usefulness of new serum tumor markers in head and neck squamous cell carcinoma , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[111]  Xiao-jun Zhou,et al.  Expression of CD34, α-Smooth Muscle Actin and Transforming Growth Factor-β1 in Squamous Intraepithelial Lesions and Squamous Cell Carcinoma of the Cervix , 2009 .

[112]  R. Moll Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors. , 1998, Sub-cellular biochemistry.

[113]  Sung Won Kim,et al.  Clinical significance of melanoma‐associated antigen A1–6 expression in sputum of patients with squamous cell carcinoma of the larynx and hypopharynx , 2016, Head & neck.

[114]  G. Sauter,et al.  Prognostic relevance of MAGE‐A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: A tissue microarray study , 2002, International journal of cancer.

[115]  D. Crowe,et al.  Role of microRNA-138 as a potential tumor suppressor in head and neck squamous cell carcinoma. , 2013, International review of cell and molecular biology.

[116]  E. D. Bal de Kier Joffé,et al.  Circulating 92‐kilodalton matrix metalloproteinase (MMP‐9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma , 2002, Cancer.

[117]  W. Hong,et al.  Focus on head and neck cancer. , 2004, Cancer cell.

[118]  L. Zhang,et al.  Overexpression of cytokeratin 17 protein in oral squamous cell carcinoma in vitro and in vivo. , 2009, Oral diseases.

[119]  Jonathan R. Clark,et al.  BASIC SCIENCE REVIEW , 2006 .

[120]  S. Faivre,et al.  Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial. , 2013, The Lancet. Oncology.